Pages that link to "Q76159818"

The following pages link to Clinical evaluation of 1-hydrazinophthalazine (C-5968) in hypertension, with special reference to alternating treatment with hexamethonium (Q76159818):

Displaying 9 items.

• Cardiovascular and Renal Responses to the Combination of Hexamethonium and 1-Hydrazinophthalazine (Apresoline®) in Hypertensive Subjects1 (Q33731591) (← links)
• A comparison of the effects of hexamethonium alone and in combination with 1-hydrazinophthalazine (apresoline) in the treatment of hypertension (Q36472169) (← links)
• The clinical evaluation and management of hypertension (Q37007868) (← links)
• Cerebral circulation and metabolism in toxemia of pregnancy; observations on the effects of veratrum viride and apresoline (1-hydrazinophthalazine). (Q51345553) (← links)
• 1-Hydrazinophthalazine (apresoline) in hypertension (Q73404739) (← links)
• Apresoline (hydralazine hydrochloride) and its use in cases of hypertensive pregnancy (Q73553691) (← links)
• The clinical use of apresoline in the toxemias of pregnancy: a preliminary report (Q73604332) (← links)
• [Comparative clinical studies on the effect of hydrazinophthalazine and Rauwolfia alkaloid reserpin on the blood pressure] (Q73663950) (← links)
• Management of the patient with primary (essential) hypertension (Q78635449) (← links)